Optimizing care for patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)

The Institute for Health Economics (IHE) conducted a roundtable on PF-ILD, in November 2021 and policy recommendations from the diverse stakeholder group provided some guidance on areas to focus on to improve the lives of those living with progressive fibrosing interstitial lung disease. Key actions identified at the roundtable included: increased surveillance for early identification of those needing services; accelerated implementation of multi-disciplinary guidance; investment in patient navigators to support patients and families; and implementing hub-and-spoke models of care (with centralized hubs linked to well-trained primary care teams).  The work was supported through funding from Boehringer Ingelheim (Canada) Ltd.